Renin-angiotensin-aldosterone system (RAAS) inhibitor, Ramipril, Purity ≥98%

Synonym: 87333-19-5; Tritace; Altace; (2S,3aS,6aS)-1-[(2S)-2-[[(2S)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrole-2-carboxylic acid; Renin-angiotensin-aldosterone system (RAAS) inhibitor

MDL: MFCD00865775
CAS Number: 87333-19-5
Compound CID: 5362129

Product Size

100 mg; 250 mg; 500 mg; 1 g

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

Ramipril, soluble in DMSO and ethanol and insoluble in water, is an effective cell metabolism inhibitor, that has the ability to prevent the pathway of angiotensin-converting enzyme (ACE) by inhibiting endocrinology-hormones. The molecular weight of the compound is 416.51, and its molecular formula is C₂₃H₃₂N₂O₅. It targets the ACE.

Molecular Weight

416.51

Molecular Formula

C₂₃H₃₂N₂O₅

Targets

ACE

Form

Lyophilized powder

Purity

≥98%

Impurities

Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.

Solubility

In vitro: DMSO: 76 mg/mL (182.46 mM); Water: insoluble; Ethanol: 76 mg/mL (182.46 mM); In vivo: 30% PEG400 + 0.5% Tween80 + 5% propylene glycol, 28 mg/mL

Identity

Confirmed by NMR/HPLC/MS.

Applications

Ramipril can be studied extensively for its potential therapeutic applications in the treatment of hypertension, heart failure, and reducing the risk of myocardial infarction and stroke.